logo

For the Inventor, By the Inventor

Welwyn, United Kingdom

Robert W Lambert

This inventor holds 16 USPTO granted patents, primarily in Antiviral Compounds. Top assignee: Hoffmann-La Roche Inc.. Active years: 1977-1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert W Lambert. Retrieved from https://idiyas.com/inventor/robert-w-lambert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16

% Patents Active = 100.0

Average Co-Inventor Count = 4.1

ph-index = 8

Forward Citations = 252(Granted Patents)


Location History:

  • Welwyn, EN (1977)
  • Welwyn, GB (1978 - 1991)

Company Filing History:

goldMedal16 out of 5,027 
 
Hoffmann-La Roche Inc.
 patents

Years Active: 1977-1991

Loading Chart...
Areas of Expertise:
Pyrimidine Derivatives
Antiviral Agent
Pharmaceutical Compositions
Anthypertensive
Pyridazo Compounds
Pyrazolo Compounds
Peptide Derivatives
Antibiotic Properties
Halo-Phosphonopeptides
Acyl Derivatives
16 patents (USPTO):Explore Patents
1. 5010060 - Method of treating herpes simplex viral infection employing pyrimidine (1991-04-23),
2. 4956346 - Pyrimidine derivatives as an antiviral agent (1990-09-11),
3. 4886785 - Pyrimidine derivatives, pharmaceutical compositions and method of using (1989-12-12),
4. 4882316 - Pyrimidine derivatives (1989-11-21),
5. 4851519 - Pyrimidine derivatives (1989-07-25),
6. 4808713 - Anthypertensive pyridazo [1,2-a][1,2]diazepines (1989-02-28),
7. 4772701 - Pyridazo[1,2]pyridazines and pyrazolo[1,2]pyridazines as (1988-09-20),
8. 4658024 - Pyrazolo [1,2-a][1,2]-diazepines useful as antihypertensives (1987-04-14),
9. 4512924 - Pyridazo[1,2-a][1,2]diazepines (1985-04-23),
10. 4250085 - Acyl derivatives (1981-02-10),
11. 4143134 - Halo-phosphonopeptides (1979-03-06),
12. 4134972 - Compositions having antibiotic properties (1979-01-16),
13. 4128542 - Peptide derivatives (1978-12-05),
14. 4127649 - Compositions having antibiotic properties (1978-11-28),
15. 4100275 - Compositions having antibiotic properties (1978-07-11),

Title: The Innovative Contributions of Robert W. Lambert

Introduction

Robert W. Lambert is a distinguished inventor based in Welwyn, GB, known for his significant contributions to the field of antiviral research. With a remarkable portfolio of 16 patents, Lambert has made strides in developing methods to combat viral infections, particularly herpes simplex.

Latest Patents

Among his latest patents, Lambert has developed a method of treating herpes simplex viral infection employing pyrimidine compounds. These compounds are characterized by specific formulas that include halogen, C1-4-alkyl, and other functional groups. Additionally, he has patented pyrimidine derivatives as antiviral agents, which also feature complex chemical structures designed to enhance their efficacy against viral infections.

Career Highlights

Lambert's career is marked by his association with Hoffmann-La Roche Inc., a leading pharmaceutical company where he has contributed to groundbreaking research and development. His work has not only advanced scientific understanding but has also paved the way for new therapeutic options in the treatment of viral infections.

Collaborations

Throughout his career, Lambert has collaborated with notable colleagues, including Cedric H. Hassall and Frank R. Atherton. These partnerships have fostered a collaborative environment that has been instrumental in driving innovation and achieving significant research milestones.

Conclusion

Robert W. Lambert's innovative work in antiviral research exemplifies the impact of dedicated inventors in the medical field. His contributions continue to influence the development of effective treatments for viral infections, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…